4.4 Article

Pentraxin-3 as a prognostic marker in patients with small-cell lung cancer

Related references

Note: Only part of the references are listed.
Article Oncology

Clinical Significance and Prognostic Value of Pentraxin-3 as Serologic Biomarker for Lung Cancer

Dai Zhang et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)

Article Critical Care Medicine

Lung Cancer in China Challenges and Interventions

Jun She et al.

CHEST (2013)

Article Cardiac & Cardiovascular Systems

Pentraxin 3 in the assessment of ventilator-associated pneumonia: An early marker of severity

Qionghua Lin et al.

HEART & LUNG (2013)

Article Cardiac & Cardiovascular Systems

Current Readings: Pathology, Prognosis, and Lung Cancer

James H. Suh

SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY (2013)

Article Oncology

Pentraxin-3 Is a Novel Biomarker of Lung Carcinoma

Eleftherios P. Diamandis et al.

CLINICAL CANCER RESEARCH (2011)

Article Gastroenterology & Hepatology

Aberrant methylation of the 3q25 tumor suppressor gene PTX3 in human esophageal squamous cell carcinoma

Jun-Xiong Wang et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2011)

Review Biochemistry & Molecular Biology

Immunity, Inflammation, and Cancer

Sergei I. Grivennikov et al.

Review Cell Biology

Role of the soluble pattern recognition receptor PTX3 in vascular biology

Marco Presta et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2007)

Review Critical Care Medicine

Prognostic factors in non-small cell lung cancer - A decade of progress

MD Brundage et al.

CHEST (2002)

Article Radiology, Nuclear Medicine & Medical Imaging

Improved response of colon cancer xenografts to radioimmunotherapy with pentoxifylline treatment

S Kinuya et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2001)